What are the safety rules for the reversal of the neuromuscular blockade?;Quelles sont les regles de securite de la decurarisation?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 19, Issue SUPPL. 2, 2000, Pages 398-402

  Baurain, M J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; GLYCOPYRRONIUM BROMIDE; MIVACURIUM; NEOSTIGMINE; PANCURONIUM; PYRIDOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT;

BRADYCARDIA; BRONCHOSPASM; CONFERENCE PAPER; DRUG SAFETY; EPIDEMIOLOGICAL DATA; HUMAN; HYPERSALIVATION; INCIDENCE; MANOMETRY; MORBIDITY; MORTALITY; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; PROSPECTIVE STUDY; ANESTHESIA; DRUG EFFECT; NEUROMUSCULAR SYNAPSE; POSTOPERATIVE COMPLICATION; REVIEW; SAFETY; STANDARD; SURGERY;

ANESTHESIA; HUMANS; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS; SAFETY; SURGICAL PROCEDURES, OPERATIVE;

EID: 0033819474     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Reversal of neuromuscular blockade
2. Reversal of non-depolarizing neuromuscular blockade
3. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans
4. Recovery of airway protection compared with ventilation in humans after paralysis with curare
5. Residual curarization in the recovery room
6. Partial curarization in the post operative period
7. Postoperative neuromuscular function
8. Residual curarization: A comparative study of atracurium and pancuronium
9. Postoperative neuromuscular blockade: A comparison between atracurium, vecuronium and pancuronium
10. Residual curarization in the recovery room: Atracurium versus gallamine
11. The frequency of residual blockade following atracurium, vecuronium and pancuronium (a multicenter randomized study)
12. Recovery from neuromuscular blockade: Residual curarisation following atracurium or vecuronium by bolus dosing or infusions
13. Comparative use of muscle relaxants and their reversal in three European countries: A survey in France, Germany and Great Britain
14. Comparison of recovery after neuromuscular blockade by atracurium or pancuronium
15. Recovery of neuromuscular function and postoperative morbidity following blockade by atracurium, alcuronium and vecuronium
16. Anaesthesia-related surgical mortality
17. Special Committee Investigating Deaths Under Anaesthesia: Report on 745 classified cases
18. Anaesthesia mortality in New South Wales
19. Admission to the intensive care unit after complications of anaesthetic techniques over 10 years
20. Complications associated with anaesthesia: A prospective survey in France
21. Residual neuromuscular block is a risk factor for postoperative pulmonary complications
22. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block
23. The relation between the response to train-of-four stimulation and receptor occlusion during competitive neuromuscular block
24. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block
25. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response
26. Ventilation and neuromuscular blocking drugs
27. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants?
28. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans
29. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers
30. Susceptibility to upper airway obstruction during partial neuromuscular block
31. Clinical recovery and train of four ratio measured mechanically ans electromyographically following atracurium
32. Clinical, electrical and mechanical correlations during recovery from neuromuscular blockade with vecuronium
33. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium
34. Acceleromyography improves detection of residual neuromuscular blockade in children
35. Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium
36. Tactile and visual evaluation of the response to train-of-four nerve stimulation
37. Manual evaluation of residual curarization using double burst stimulation: A comparison with train-of-four
38. How useful is visual and tactile assessment of neuromuscular blockade using a peripheral stimulator?
39. Comparison of double burst and train-of-four stimulation to assess neuromuscular blockade in children
40. Comparison of visual and measured train-of-four recovery after vecuronium induced neuromuscular blockade using two anaesthetic techniques
41. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium or atracurium-induced neuromuscular blockade
42. Clinical assessment of the muscular response to tetanic nerve stimulation
43. Tactile evaluation of the response to double burst stimulation decreases, but not eliminate, the problem of postoperative residual paralysis
44. Evaluation of residual neuromuscular block using train-of-four and double burst stimulation at the index finger
45. Visual evaluation of residual curarization in anesthetized patients using hundred-hertz, five second tetanic stimulation at the adductor pollicis muscle
46. Comparison of neostigmine-induced recovery with spontaneous recovery from mivacurium-induced neuromuscular block
47. Can the neuromuscular transmission recovery be complete after the use of neostigmine in reversing the neuromuscular block by rocuronium, vecuronium, atracurium and pancuronium
48. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium
49. Low and high frequencies stimulation tests to characterise the effects action of edrophonium on a vecuronium-induced neuromuscular block
50. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block
51. Residual postoperative paralysis: Pancuronium versus mivacurium, does it matter?
52. Train-of-four quantitation of competitive neuromuscular block
53. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade
54. The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade
55. Influence and relative sensitivities of 50 Hz and 100 Hz tetanic stimuli on subsequent tetanic fade ratios in patients receiving vecuronium